Health Stock on the Rise
This stock could be a major success story in 2021.
Here's why.
Georgia Erbez, insider at Harpoon Therapeutics
Georgia Erbez Insider Alerts

Get notified the next time Georgia Erbez buys or sells Harpoon Therapeutics stock. Enter your email address below to get our daily insider buying and selling report.

Georgia Erbez Insider Information

Georgia L. Erbez joined Harpoon in October 2018 as Chief Financial Officer, bringing financial, operational and strategic advisory experience in multiple biotech settings, as well as investment banking. She previously served as Chief Business Officer and Chief Financial Officer of Zosano Pharma, a therapeutics company focused on migraine. She served as Chief Financial Officer and Executive Vice President of Asterias Biotherapeutics and Chief Financial Officer, Secretary and Treasurer of Raptor Pharmaceuticals, where she helped to navigate the company through a growth period that included its first drug approval and subsequent commercial launch. Prior to Raptor, Ms. Erbez was a Managing Director, Healthcare Investment Banking at Collins Stewart, a Founder and Managing Director at Beal Advisors, and a senior level investment banker at Jefferies & Company, Inc. and Cowen and Company. She has also held positions at the investment banks Hambrecht & Quist and Alex. Brown & Sons Inc. Ms. Erbez currently serves as a member of the Board of Directors of Altibio, Inc, Sierra Oncology (Nasdaq: SRRA) and Neurana Pharmaceuticals. Ms. Erbez received a Bachelor of Arts degree, International Relations from the University of California at Davis.

What is Georgia Erbez's net worth?

The estimated net worth of Georgia Erbez is at least $283,279.08 as of August 18th, 2020. Ms. Erbez owns 47,292 shares of Harpoon Therapeutics stock worth more than $283,279 as of November 30th. This net worth estimate does not reflect any other investments that Ms. Erbez may own. Learn More.

What is Georgia Erbez's salary?

As the CFO of Harpoon Therapeutics, Inc., Ms. Erbez earned a total compensation package of $1,023,284.00 in 2020. Ms. Erbez earned a salary of $390,000.00, options awards of $468,734.00, non-equity compensation of $156,000.00, and other compensation of $8,550.00.

How do I contact Georgia Erbez?

The corporate mailing address for Ms. Erbez and other Harpoon Therapeutics executives is 131 OYSTER POINT BLVD SUITE 300, SOUTH SAN FRANCISCO CA, 94080. Harpoon Therapeutics can also be reached via phone at (650) 443-7400 and via email at [email protected]

Has Georgia Erbez been buying or selling shares of Harpoon Therapeutics?

Georgia Erbez has not been actively trading shares of Harpoon Therapeutics in the last ninety days. Most recently, on Wednesday, September 22nd, Georgia Erbez bought 10,300 shares of Harpoon Therapeutics stock. The stock was acquired at an average cost of $8.10 per share, with a total value of $83,430.00.

Who are Harpoon Therapeutics' active insiders?

Harpoon Therapeutics' insider roster includes Georgia Erbez (CFO), Ansbert Gadicke (Major Shareholder), and Holger Wesche (Insider).

Are insiders buying or selling shares of Harpoon Therapeutics?

In the last twelve months, Harpoon Therapeutics insiders bought shares 1 times. They purchased a total of 10,300 shares worth more than $83,430.00. In the last twelve months, insiders at the sold shares 29 times. They sold a total of 1,769,383 shares worth more than $36,663,672.51. The most recent insider tranaction occured on September, 22nd when CFO Georgia Erbez bought 10,300 shares worth more than $83,430.00. Insiders at Harpoon Therapeutics own 4.4 % of the company.

Information on this page was last updated on 9/22/2021.

Georgia Erbez Insider Trading History at Harpoon Therapeutics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/22/2021Buy10,300$8.10$83,430.00View SEC Filing Icon  
8/18/2020Buy2,098$11.60$24,336.8047,292View SEC Filing Icon  
7/31/2020Buy1,817$10.92$19,841.6447,292View SEC Filing Icon  
1/21/2020Buy6,700$14.09$94,403.0047,292View SEC Filing Icon  
See Full Table

Georgia Erbez Buying and Selling Activity at Harpoon Therapeutics

This chart shows Georgia Erbez's buying and selling at Harpoon Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Harpoon Therapeutics Company Overview

Harpoon Therapeutics logo
Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA.
Read More

Today's Range

Now: $5.99
Low: $5.99
High: $6.84

50 Day Range

MA: $7.07
Low: $5.99
High: $8.37

2 Week Range

Now: $5.99
Low: $5.80
High: $25.24

Volume

174,932 shs

Average Volume

310,130 shs

Market Capitalization

$196.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74
Fed Decriminalization of Cannabis Could Spark New Pot Stock Boom
With Democrats now controlling both houses of Congress and the executive branch, cannabis decriminalization on the federal level could be months away. This could result in established Washington State weed companies being able to market across state lines -- setting off a bidding war for quality stocks at reasonable prices.
Get All the Details on #1 Stock